To recover your password please fill in your email address
Please fill in below form to create an account with us
The Australian Clinical Trials Alliance (ACTA) and the Australian Commission on Safety and Equality in Health Care have published a landmark report outlining the economic benefits of investigator-initiated clinical trials.
The report finds that if the results of 25 high-impact clinical trials were implemented in 65% of the eligible Australian patient populations:
Benefits would exceed costs if the results of these trials were implemented in only 11% of the eligible patient populations.
For every $1 awarded in National Health and Medical Research Council (NHMRC) grants to the 25 trials, a return of $51.10 was achieved.
National Health and Medical Research Funding provided to all Australian trial investigator networks between 2004 and 2014 accounts for 9% of the $2 billion gross benefit estimated.
Download a copy of the full report here.